Consequences of Using Post- or Prebronchodilator Reference Values in Interpreting Spirometry

Abstract

<b>Rationale:</b> Postbronchodilator spirometry is used for the diagnosis of chronic obstructive pulmonary disease. However, prebronchodilator reference values are used for spirometry interpretation. <b>Objectives:</b> To compare the resulting prevalence rates of abnormal spirometry and study the consequences of using pre- or postbronchodilator reference values generated within SCAPIS (Swedish CArdioPulmonary bioImage Study) when interpreting postbronchodilator spirometry in a general population. <b>Methods:</b> SCAPIS reference values for postbronchodilator and prebronchodilator spirometry were based on 10,156 and 1,498 never-smoking, healthy participants, respectively. We studied the associations of abnormal spirometry, defined by using pre- or postbronchodilator reference values, with respiratory burden in the SCAPIS general population (28,851 individuals). <b>Measurements and Main Results:</b> Bronchodilation resulted in higher predicted medians and lower limits of normal (LLNs) for FEV₁/FVC ratios. The prevalence of postbronchodilator FEV₁/FVC ratio lower than the prebronchodilator LLN was 4.8%, and that of postbronchodilator FEV₁/FVC lower than the postbronchodilator LLN was 9.9%, for the general population. An additional 5.1% were identified as having an abnormal postbronchodilator FEV₁/FVC ratio, and this group had more respiratory symptoms, emphysema (13.5% vs. 4.1%; <i>P</i> < 0.001), and self-reported physician-diagnosed chronic obstructive pulmonary disease (2.8% vs. 0.5%, <i>P</i> < 0.001) than subjects with a postbronchodilator FEV₁/FVC ratio greater than the LLN for both pre- and postbronchodilation. <b>Conclusions:</b> Pre- and postbronchodilator spirometry reference values differ with regard to FEV₁/FVC ratio. Use of postbronchodilator reference values doubled the population prevalence of airflow obstruction; this was related to a higher respiratory burden. Using postbronchodilator reference values when interpreting postbronchodilator spirometry might enable the identification of individuals with mild disease and be clinically relevant.